| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 393,7 k € | -12.1% | 448,0 k € | +9.4% | 409,4 k € | +16.8% | 350,3 k € | +10.8% | 316,1 k € | +11.5% | 283,5 k € | -70.8% | 970,9 k € | +20.5% | 805,7 k € | +4.1% | 774,0 k € | -6.3% | 825,6 k € | +9.2% | 756,3 k € | +86.3% | 406,0 k € | +7.7% | 376,9 k € | -2.7% | 387,5 k € | +2.9% | 376,7 k € | +18.1% | 319,0 k € | -4.0% | 332,4 k € | +10.4% | 301,1 k € | +20.3% | 250,3 k € | |
| EBITDA | 390,3 k € | -12.2% | 444,7 k € | +9.4% | 406,4 k € | +17.0% | 347,3 k € | +10.9% | 313,3 k € | +12.2% | 279,3 k € | -71.1% | 967,3 k € | +20.8% | 801,0 k € | +4.0% | 770,1 k € | -4.4% | 805,2 k € | +6.9% | 753,5 k € | +85.8% | 405,5 k € | +8.4% | 374,2 k € | -2.8% | 384,9 k € | +2.8% | 374,3 k € | +18.3% | 316,5 k € | -4.1% | 329,9 k € | +10.6% | 298,3 k € | +20.5% | 247,6 k € | |
| Operating profit | 353,9 k € | -11.5% | 399,8 k € | +11.4% | 358,7 k € | +20.4% | 297,9 k € | +12.7% | 264,4 k € | +18.7% | 222,8 k € | -75.5% | 910,7 k € | +26.1% | 722,1 k € | +5.6% | 683,9 k € | -1.9% | 696,9 k € | +1.6% | 685,6 k € | +112.4% | 322,7 k € | +4.0% | 310,3 k € | -5.0% | 326,6 k € | +4.7% | 311,8 k € | +25.4% | 248,7 k € | -4.1% | 259,3 k € | +16.1% | 223,2 k € | +29.7% | 172,1 k € | |
| Profit/loss | 275,1 k € | -7.9% | 298,7 k € | +23.8% | 241,3 k € | +22.4% | 197,1 k € | +27.6% | 154,5 k € | +156.1% | 60,3 k € | -86.6% | 449,5 k € | +15.5% | 389,0 k € | +39.7% | 278,4 k € | -37.6% | 446,4 k € | +0.7% | 443,3 k € | +91.9% | 231,0 k € | +11.5% | 207,2 k € | -9.0% | 227,6 k € | +3.7% | 219,4 k € | +25.2% | 175,3 k € | -0.7% | 176,6 k € | +18.7% | 148,8 k € | +35.6% | 109,7 k € | |
| Equity | 2,6 M € | +9.7% | 2,4 M € | +12.0% | 2,1 M € | +10.1% | 1,9 M € | -26.6% | 2,6 M € | +5.2% | 2,5 M € | +2.5% | 2,5 M € | -1.3% | 2,5 M € | +18.6% | 2,1 M € | +15.3% | 1,8 M € | +32.5% | 1,4 M € | +206.8% | 447,0 k € | -40.5% | 750,8 k € | +33.7% | 561,6 k € | -17.5% | 681,1 k € | -24.3% | 900,0 k € | +24.2% | 724,7 k € | +12.8% | 642,2 k € | +16.0% | 553,4 k € | |
| Total assets | 3,1 M € | +8.4% | 2,9 M € | +7.7% | 2,7 M € | +7.0% | 2,5 M € | -10.6% | 2,8 M € | +9.3% | 2,5 M € | -1.1% | 2,6 M € | +2.3% | 2,5 M € | +18.3% | 2,1 M € | +7.6% | 2,0 M € | +34.1% | 1,5 M € | +29.9% | 1,1 M € | +40.5% | 806,1 k € | +29.8% | 621,2 k € | -39.4% | 1,0 M € | +2.3% | 1,0 M € | -0.4% | 1,0 M € | +13.5% | 887,2 k € | +10.3% | 804,1 k € | |
| Cash | 691,5 k € | -24.1% | 910,6 k € | +35.1% | 673,9 k € | -20.9% | 852,3 k € | +35.7% | 628,0 k € | +24.8% | 503,4 k € | +0.2% | 502,2 k € | -15.2% | 592,1 k € | +16.0% | 510,2 k € | +26.7% | 402,5 k € | +231.0% | 121,6 k € | -39.4% | 200,6 k € | -34.5% | 306,1 k € | +77.4% | 172,6 k € | -23.3% | 224,8 k € | -52.1% | 469,8 k € | +20.8% | 388,8 k € | +178.4% | 139,6 k € | -25.8% | 188,2 k € | |
| Debts | 474,8 k € | +1.5% | 467,8 k € | -10.2% | 521,0 k € | -4.3% | 544,4 k € | +307.2% | 133,7 k € | +380.4% | 27,8 k € | -76.1% | 116,6 k € | +351.5% | 25,8 k € | 0.0% | 25,8 k € | -83.2% | 154,0 k € | +55.5% | 99,1 k € | -85.5% | 685,2 k € | +1141.8% | 55,2 k € | -7.4% | 59,6 k € | -82.7% | 344,6 k € | +234.4% | 103,0 k € | -63.5% | 282,4 k € | +15.2% | 245,1 k € | -2.3% | 250,7 k € | |
| Staff | — | — | — | — | — | — | — | — | — | 0,6 | — | — | — | — | — | — | — | — | — | |||||||||||||||||||
Private company with limited liability · Lennik · incorporated on 04/03/1999
Private company with limited liability profitable and well capitalised. Cash position declining (-24.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DOKTER RENARD BIRGIT is a Private company with limited liability incorporated in 1999. Its main activity is: Specialist medical practice activities. Its registered office is in Lennik.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette